Angelman syndrome

Search Trials
A Study To Assess Distribution Of RO7248824 In The Central Nervous System Following Single Intrathecal Doses Of [89zr] Labeled RO7248824 In Healthy Male Participants
Status:
Recruiting
Last Changed:
Jun 24, 2022
First Changed:
Apr 28, 2021
Disease(s):
Angelman Syndrome
Intervention(s):
RO7248824
Angelman Syndrome (AS) Biomarker Study
Status:
Completed
Last Changed:
Jan 28, 2022
First Changed:
Sep 25, 2019
Disease(s):
Angelman Syndrome
Intervention(s):
Lumbar PunctureBlood Collection
A Study of OV101 in Individuals With Angelman Syndrome (AS)
Status:
Completed
Last Changed:
Nov 17, 2020
First Changed:
Sep 27, 2019
Disease(s):
Primary Disease or Condition Being Studied: Angelman Syndrome (AS)
Intervention(s):
GaboxadolPlacebo
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
Status:
Terminated
Last Changed:
Feb 4, 2022
First Changed:
Mar 20, 2019
Disease(s):
Angelman Syndrome
Intervention(s):
OV101
A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
Status:
Recruiting
Last Changed:
Feb 24, 2022
First Changed:
Feb 6, 2020
Disease(s):
Angelman Syndrome
Intervention(s):
GTX-102

Connect. Empower. Inspire.